首页> 外文会议>World Congress for Chinese Biomedical Engineers >Treatment of osteosarcoma with high-intensity focused ultrasound: Preliminary clinical outcomes in one center
【24h】

Treatment of osteosarcoma with high-intensity focused ultrasound: Preliminary clinical outcomes in one center

机译:高强度聚焦超声治疗骨肉瘤:一个中心的初步临床结果

获取原文

摘要

OBJECTIVE: To evaluate the effect of high-intensity focused ultrasound (HIFU) in the treatment ofosteosarcoma.PATIENTS AND METHODS: From November 2000 to May 2004, by using a model JC focusedultrasound therapeutic system, 25 osteosarcoma patients (15 males and 10 females aging 6 - 44 yearsold and with mean ages of 17.7±8.5 years old; surgical stage were 20 Iib and 5 IIIb) receivedextracorporeal HIFU ablation in our center. All patients received conventional neoadjuvantchemotherapy and adjuvant chemotherapy after HIFU ablation. All patients were followed with clinicalexaminations, chest x-ray, bone scan and enhanced MRI every 3 to 6 months for two years.RESULTS: The nuclide uptake in bone scan and gadolinium enhancement in MRI of the target lesionwas elminated after effective HIFU ablation. A total of 35 HIFU sessions were performed to the 25patients. Local complete ablations evaluated by images were achieved in 23 patients (92%), in which19 patients received one HIFU session, 2 received 2 sessions and 2 received 3 sessions. Till now, themedian follow-up times were 21 months (ranging 1-43 months. There were 24 patients (96%) survivedwith 20 months of median survival time, 19 patients (76%) survived relapse-free, 4 patients newlydeveloped lung metastasis, and 2 developed local recurrence. Eleven major complications such asperipheral nerve injury and pathologic fracture were observed in 10 patients. One patient died of lungmetastasis 5 months after HIFU ablation.CONCLUSIONS: The preliminary results showed that effective and complete ablation of osteosarcomalesions could be achieved by extracorporeal HIFU, which may become a new limb salvaging methodsfor patients with osteosarcoma.
机译:目的:评价高强度聚焦超声(HIFU)治疗骨肉瘤的效果。从2000年11月至2004年5月,采用JC聚焦超声治疗系统,对25例骨肉瘤患者(男性15例,女性10例)进行了研究。年龄在6至44岁之间,平均年龄为17.7±8.5岁;手术分期为20 Iib和5 IIIb)在我们中心接受了体外HIFU消融。所有患者均接受常规新辅助化疗和HIFU消融后的辅助化疗。所有患者均接受临床检查,胸部X线检查,骨扫描和MRI增强检查,为期两年,每3至6个月。结果:有效HIFU消融后,目标病灶的骨扫描摄取核素和g增强MRI消失。 25位患者共进行了35次HIFU疗程。通过图像评估的局部完全消融在23例患者中(92%),其中19例接受了一次HIFU疗程,2例接受了2疗程,2例接受了3疗程。截止目前,主题患者随访时间为21个月(1-43个月),其中存活24例(96%),中位生存时间20个月,无复发19例(76%),新发肺转移4例。 ,其中2例发生局部复发,在10例患者中观察到11种主要并发症,例如周围神经损伤和病理性骨折,其中1例患者在HIFU消融后5个月死于肺转移。结论:初步结果表明,可以有效,完全地消融骨肉瘤体外HIFU治疗可能成为骨肉瘤患者新的肢体抢救方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号